SEMAGLUTIDE

Semaglutide

GLP-1 analog research peptide (Glucagon-Like Peptide-1), studied in preclinical models for GLP-1 receptor signaling and its role in metabolic regulation.

Available in France as lyophilized powder, in vials of 5 mg, 10 mg and 20 mg, intended exclusively for laboratory research.

Product intended exclusively for laboratory research. Not intended for human or animal consumption.

What is Semaglutide?

Semaglutide is a research peptide belonging to the class of GLP-1 (Glucagon-Like Peptide-1) analogs. GLP-1 is a natural incretin hormone involved in glucose regulation and metabolic signaling.

As a synthetic analogue, Semaglutide is being studied for its interaction with the GLP-1 receptor , a key target in metabolic research. It serves as a tool for preclinical studies of incretin signaling pathways in experimental models.